Literature DB >> 7592673

Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements.

M D Siegel1, D H Zhang, P Ray, A Ray.   

Abstract

Interleukin-5 (IL-5) plays a central role in the growth and differentiation of eosinophils and contributes to several disease states including asthma. Accumulating evidence suggests a role for cAMP as an immunomodulator; agents that increase intracellular cAMP levels have been shown to inhibit production of cytokines predominantly produced by T helper (Th) 1 cells such as IL-2 and interferon gamma (IFN-gamma). In contrast, the production of IL-5, predominantly produced by Th2 cells, is actually enhanced by these agents. In this report, we have performed transient transfection experiments with IL-5 promoter-reporter gene constructs, DNase I footprinting assays, and electrophoretic mobility shift assays to investigate the key regulatory regions necessary for activation of the IL-5 promoter by dibutyryl cAMP and phorbol esters in the mouse thymoma line EL-4. Taken together, our data demonstrate the critical importance of two sequences within the IL-5 5'-flanking region for activation by these agents in EL-4 cells: one, a highly conserved 15-base pair element present in genes expressed by Th2 cells, called the conserved lymphokine element 0 (CLE0; located between -53 and -39 in the IL-5 promoter), and the other, two overlapping binding sites for the transcription factor GATA-3 (but not GATA-4) between -70 and -59. Taken together, our data suggest that activation via the unique sequence combination GATA/CLE0 results in selective expression of the IL-5 gene in response to elevated levels of intracellular cAMP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592673     DOI: 10.1074/jbc.270.41.24548

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation.

Authors:  A Ray; L Cohn
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs.

Authors:  T Yamagata; K Mitani; H Oda; T Suzuki; H Honda; T Asai; K Maki; T Nakamoto; H Hirai
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

3.  DNase I footprinting of the human interleukin-5 gene promoter.

Authors:  D J Cousins; D Richards; D M Kemeny; S Romagnani; T H Lee; D Z Staynov
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

4.  GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model.

Authors:  Thomas Höfer; Holger Nathansen; Max Löhning; Andreas Radbruch; Reinhart Heinrich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-26       Impact factor: 11.205

5.  GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells.

Authors:  Sung-Yun Pai; Morgan L Truitt; I-Cheng Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

6.  Computational identification of gene-social environment interaction at the human IL6 locus.

Authors:  Steven W Cole; Jesusa M G Arevalo; Rie Takahashi; Erica K Sloan; Susan K Lutgendorf; Anil K Sood; John F Sheridan; Teresa E Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

Review 7.  T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.

Authors:  Jinfang Zhu
Journal:  Cytokine       Date:  2015-06-01       Impact factor: 3.861

Review 8.  Differentiation of effector CD4 T cell populations (*).

Authors:  Jinfang Zhu; Hidehiro Yamane; William E Paul
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

9.  Integration of calcium and cyclic AMP signaling pathways by 14-3-3.

Authors:  C W Chow; R J Davis
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

10.  Impact of cAMP on the T-cell response to type II collagen.

Authors:  Patricia Ozegbe; Andrew D Foey; Salman Ahmed; Richard O Williams
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.